The Direct and Indirect Costs of Colorectal Cancer in Vietnam: An Economic Analysis from a Social Perspective

Tran, Binh Thang; Choi, Kui Son; Nguyen, Thanh Xuan; Sohn, Dae Kyung; Kim, Sun‐Young; Suh, Jae Kyung; Phan, Van Sang; Pham, Huu Tri; Nguyen, Minh Hanh; Nguyễn, Thanh Bình; Hoang, Huu Khoi; Nguyễn, Thị Thanh Bình; Nguyen, Minh Tú; Oh, Jin-Kyoung

doi:10.3390/ijerph18010012

Cited by 17 publications

(24 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Consequently, the cost of patient companions’ absenteeism due to accompanying patients as well as patient care was high. The results of the present study are is inconsistent with those of the studies by Tran et al (2021), 11 Vahdatimanesh et al (2017), 14 and Byun et al (2014), 13 in which it had been reported that mean indirect costs were the highest ones. The difference can be because of the several premature deaths due to colorectal cancer and their related costs in these 3 studies.…”

Section: Discussioncontrasting

confidence: 99%

Economic Burden of Colorectal Cancer: A Case of Fars, Iran

et al. 2021

View full text Add to dashboard Cite

Among cancers, colorectal cancer is the third most common cancer in the world and the fourth leading cause of cancer deaths worldwide. Some studies have shown that the incidence of colorectal cancer is increasing in Iran and in Fars province. The present study aimed to determine the economic burden of colorectal cancer in patients referred to the referral centers affiliated to Iran, Shiraz University of Medical Sciences in 2019 from the patients’ perspective. This is a partial economic evaluation and a cost-of-illness study conducted cross-sectionally in 2019. All the patients with colorectal cancer who had been referred to the referral centers affiliated to Iran, Shiraz University of Medical Sciences, and had medical records were studied through the census method (N = 96). A researcher-made data collection form was used to collect the cost data. The prevalence-based and bottom-up approaches were also used in this study. The human capital approach was applied to calculate indirect costs. The mean annual cost per patient with colorectal cancer in the present study was $10930.98 purchasing power parity (PPP) (equivalent to 5745.29 USD), the main part of which was the medical direct costs (74.86%). Also, among the medical direct costs per patient, the highest were those of surgeries (41.7%). In addition, the mean annual cost per patient with colorectal cancer in the country was $ 116917762 PPP (equivalent to 61451621.84 USD) in 2019. Regarding the considerable economic burden of colorectal cancer and in order to reduce the costs, these suggestions can be made: increasing the number of specialized beds through the cooperation of health donors, establishing free or low-cost accommodation centers for patients and their companions near the medical centers, using the Internet and cyberspace technologies to follow up the treatment of patients, and increasing insurance coverage and government drug subsidies on drug purchase.

show abstract

Section: Discussioncontrasting

confidence: 99%

Economic Burden of Colorectal Cancer: A Case of Fars, Iran

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Ngcamphalala et al ( 10 ) reported considerable costs of cervical cancer in Eswatini, with indirect costs accounting for 27% (USD5.3 million) of total expenditures and productivity loss due to premature mortality accounting for 67% (USD3.5 million). Likewise, a Vietnamese study describing the burden of colorectal cancer reported that the productivity costs of the cancer were about 83.58% of the overall cost, with 82.61% of future income loss occurring during the productive years ( 11 ).…”

Section: Discussionmentioning

confidence: 99%

“…Cervical cancer mortality and morbidity are high in countries where the HPV vaccine is not yet obligatory, such as Indonesia ( 6 ). And, studies from these developing countries report that cancer-related productivity loss causes about 60%–85% of the economic burden ( 4 , 11 , 14 , 15 ).…”

Section: Discussionmentioning

confidence: 99%

“…Multiple studies have described the significant economic impact of cancer in LMICs compared to high-income nations — a population-based study in 2018 about the economic impact of cervical cancer in sub-Saharan Africa reported an estimated total annual cost of cervical cancer as USD19 million ( 10 ). Likewise, the total economic cost of colorectal cancer in Vietnam was Vietnamese Dong (VND)3,041.88 billion (USD132.9 million), with indirect costs accounting for 83.58% of the total cost and 82.61% of which is future income loss ( 11 ). Notably, a Malaysian study investigating the prevalence of cancers and their corresponding risk factors reported that lung cancer, laryngeal cancer, and esophageal cancer were the three most predominant cancers and tobacco smoking was the most prevalent contributing risk factor across genders ( 12 ).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Prediction of Productivity Costs Related to Cervical Cancer Mortality in Indonesia 2018

Kristina¹,

Endarti²,

Aditama³

2022

MJMS

View full text Add to dashboard Cite

Background: Cervical cancer is the second leading cause of death in Indonesia, causing a significant societal burden. This study aims to quantify the burden of cervical cancer in terms of years of life lost (YLL) and productivity cost to support the idea that cervical cancer has substantial economic implications. Methods: Using an epidemiological approach on the prevalence data of 2018, the productivity cost and YLL were estimated by calculating the number of cervical cancer deaths, life expectancy, annual earnings and employment participation rate. Cervical cancer mortality data were obtained from the Global Cancer Observatory (GLOBOCAN) 2018, life expectancy for Indonesia from the WHO Life Tables (2019), and the annual earnings and participation rate of Indonesia were retrieved from the National Statistics Bureau (2018). Results: In 2018, there were 17,253 deaths due to cervical cancer in Indonesia, resulting in 246,350 YLL with a total productivity cost of Indonesian Rupiah (IDR)23,174 trillion. The age group of 50 years old–64 years old experienced the greatest loss of earnings (IDR12,149 trillion), followed by the 35 years old–49 years old (IDR8,944 trillion) and 20 years old–34 years old (IDR8,944 trillion) age groups. Conclusion: The productivity impact of loss of earning due to cervical cancer mortality is significant. This information may assist decision makers in allocating scarce resources among competing priorities.

show abstract

“…Additionally, cost-of-illness studies are critical to informing policy decisions on cancer prevention and control, cost-effectiveness evaluations and improving public health. 23 Costs of CRC have been assessed in many countries, such as Iran, 24 Vietnam, 25 New Zealand 26 and across the European Union, 23 and all studies have demonstrated high costs of CRC and substantial burden on the healthcare system. However, evidence on costs of CRC in China is limited.…”

Section: Strengths and Limitations Of This Studymentioning

confidence: 99%

Disease knowledge, medical experience, health-related quality of life and health-care costs among patients with advanced colorectal cancer in China: protocol for a nationwide multicentre survey

Liu

Zhang

et al. 2022

BMJ Open

View full text Add to dashboard Cite

BackgroundColorectal cancer (CRC) is one of the most common cancers in China. Most patients have developed advanced stage at diagnosis, leading to a low 5-year survival rate. To optimise prevention strategies, we planned a survey to evaluate the disease knowledge, medical experience and health-related quality of life (HRQOL) before and after the treatment of CRC, and healthcare costs among patients with advanced CRC in China.Methods and analysisThis is a nationwide, hospital-based, multicentre survey. Nineteen hospitals in seven cities were selected by multistage stratified sampling. Mainland China is divided into seven regions according to the traditional administrative district definition; two cities of each region were selected through simple random sampling, and then one tertiary cancer hospital and one general hospital were selected for each city. More than 4445 patients with CRC in the selected hospitals with stage III or IV will be enrolled in this study. The trained interviewers will collect information through patients’ self-report and/or medical records, including demographics and medical history; knowledge about CRC high-risk factors, screening procedure and treatment methods; medical experience on CRC screening, diagnosis and treatment; HRQOL before and after CRC treatment; and costs of CRC. All data will be input by two independent staff and verified using Epidata V.3.1 software. Data validation plan will be made to guide data checking. All statistical analyses will be conducted using SAS V.9.4 and SPSS V.24.0 software.Ethics and disseminationThe study was approved by the ethics committees of Henan Cancer Hospital, the leading participant hospital. Findings of this study will be disseminated through peer-reviewed open-access journals and presented as posters and/or oral sections in national and international conferences. Results will also be popularised to the public via media or the internet.

show abstract

The Direct and Indirect Costs of Colorectal Cancer in Vietnam: An Economic Analysis from a Social Perspective

Cited by 17 publications

References 26 publications

Economic Burden of Colorectal Cancer: A Case of Fars, Iran

Economic Burden of Colorectal Cancer: A Case of Fars, Iran

Prediction of Productivity Costs Related to Cervical Cancer Mortality in Indonesia 2018

Disease knowledge, medical experience, health-related quality of life and health-care costs among patients with advanced colorectal cancer in China: protocol for a nationwide multicentre survey

Contact Info

Product

Resources

About